Skip to main content
. 2019 Oct 19;8(11):835–844. doi: 10.1002/psp4.12456

Table 2.

Model parameters

Parameter Final value [Ref.]
Infliximab
Molecular weight 149,100 kDa
Hydrodynamic radius 5.34 nm [Ref. 13]
Rate of uptake into endosomal space (kup) 0.35 min −1
Dissociation constant for FcRn binding (KDFcRn) 727 nM [Ref. 45]
Dissociation constant for TNF binding (KDTNF) 30 pM [Ref. 46]
Dissociation constant for ADA binding (KDADA) 500 pM [Ref. 47]
TNF
TNF maximum plasma concentrationa (TNForgan) 0.5 pM [Ref. 25, 26, 37]
TNF factor for autoimmune disease 2 [Ref. 25, 26, 27, 28]
TNF degradation rate kdegTNF 0.0231 min−1 [Ref. 48, 49]
mAb‐TNF complex degradation rate kdegmAb-TNF 0.0231 min−1
ADA
Duration of IgM production TprodIgM 30.7 days [Ref. 36]
Lag time prior to IgG production TlagIgG 38.8 days [Ref. 36]
IgM maximum plasma concentrationa EmaxIgM
kdegIgG×EmaxIgGkdegIgM
IgG maximum plasma concentration a
EmaxIgG
136 nM
ADA (IgM) degradation rate kdegIgM 0.1 day−1 [Ref. 36]
ADA (IgG) degradation rate in healthy kdegIgG 0.014 day−1 [Ref. 36]
ADA (IgG) degradation rate in autoimmune kdegIgG 0.008 day−1 [Ref. 36]
mAb‐ADA complex degradation rate kdegmAb-ADA 0.48 day−1 [Ref. 50]
Inflamed organ
Inflammation factor for inflamed pores (IFσ) 1.5 [Ref. 31, 32, 33]
TNF factor for inflamed organ 3 [Ref. 29, 30]

Italicized values were mathematically optimized to their final value in the model building process.

ADA, antidrug antibody; FcRn, neonatal Fc receptor; mAb, monoclonal antibody; TNF, tumor necrosis factor.

Zero order synthesis rates were calculated by multiplying the degradation rate by the maximum concentration of the molecule.